Day: January 29, 2024

Bidirection Electrical Charger Market Size Worth USD 5895.6 Million in 2032 | Emergen Research

Written by Customer Service on January 29, 2024. Posted in Mergers And Acquisitions.

Growing adoption of Vehicle-to-Grid (V2G) technology by leading manufacturers, rising initiatives of governments for the expansion of electric vehicle charging infrastructure and growing need for energy self-sufficiency are expected to drive the Bidirection Electrical Charger Market revenue growth Vancouver, Jan. 29, 2024 (GLOBE NEWSWIRE) — The global bidirection electrical charger market size was USD 928.8 Million in 2022 and is expected to register a revenue CAGR of 20.4% during the forecast period. Growing adoption of Vehicle-to-Grid (V2G) technology by leading manufacturers, rising initiatives of governments for the expansion of electric vehicle charging infrastructure, increasing sales of electric vehicles across the globe, and growing need for energy self-sufficiency are expected to drive the market revenue growth. This technology,...

Vera Therapeutics Announces Proposed Public Offering of Class A Common Stock

Written by Customer Service on January 29, 2024. Posted in Public Companies.

BRISBANE, Calif., Jan. 29, 2024 (GLOBE NEWSWIRE) — Vera Therapeutics, Inc. (“Vera”), a late clinical-stage biotechnology company developing and commercializing transformative treatments for patients with serious immunologic diseases, today announced its plans to commence a public offering, subject to market and other conditions, to issue and sell $200.0 million of shares of its Class A common stock. All of the shares are being offered by Vera. In connection with the proposed offering, Vera expects to grant the underwriters a 30-day option to purchase up to an additional 15% of the shares of Class A common stock sold in the public offering. There can be no assurance as to whether or when the proposed offering may be completed or as to the actual size or terms of the proposed offering. J.P. Morgan, TD Cowen and Evercore ISI are acting...

Panbela Announces Pricing of Approximately $9.0 Million Public Offering

Written by Customer Service on January 29, 2024. Posted in Public Companies.

MINNEAPOLIS, Jan. 29, 2024 (GLOBE NEWSWIRE) — Panbela Therapeutics, Inc. (Nasdaq: PBLA), a clinical stage company developing disruptive therapeutics for the treatment of patients with urgent unmet medical needs, today announced the pricing of a public offering of (i) 4,375,000 shares of its common stock or pre-funded warrants in lieu thereof and (ii) two classes of warrants to purchase up to an aggregate of 8,750,000 shares of its common stock (the “Common Warrants”) at a purchase price of $2.06 per share and associated Common Warrants. The Common Warrants will have an exercise price of $2.06 per share, are exercisable upon issuance, and will expire five years following the date of issuance. The Common Warrants do not have any alternative cashless exercise or other provisions to adjust their exercise price beyond customary proportionate...

REE Ships P7-C Demo to FMI Truck Sales & Service; Franz Bakery, Bedmart, Indoor Billboard, PointS Tires and Kelly’s Home Center Fleets Set to Begin Evaluation of P7-C Vehicle

Written by Customer Service on January 29, 2024. Posted in Public Companies.

REE AUTOMOTIVE P7-CREE AUTOMOTIVE P7-CREE AUTOMOTIVE P7-CREE AUTOMOTIVE P7-CCOVENTRY, United Kingdom, Jan. 29, 2024 (GLOBE NEWSWIRE) — REE Automotive Ltd. (Nasdaq: REE) (“REE” or the “Company”), an automotive technology company and provider of full by-wire electric trucks and platforms, today announced that leading northwest fleets in the U.S., including Franz Bakery, Bedmart, Indoor Billboard, PointS Tires and Kelly’s Home Center, in partnership with certified REE dealer FMI Trucks, plan to evaluate the P7-C medium-duty electric demo truck. FMI Trucks is one of the first dealers to receive the brand-new P7-C electric truck from REE’s initial production batch for their fleet customers to review Powered By REE™ vehicles in real world conditions. The demo will give fleets the opportunity to experience the...

WillScot Mobile Mini to Acquire McGrath RentCorp for $3.8 Billion, Enhancing Its Position as the North American Leader in Turnkey Space Solutions

Written by Customer Service on January 29, 2024. Posted in Mergers And Acquisitions.

60% Cash and 40% Stock Transaction Provides McGrath RentCorp Shareholders with $123 Per Share and Upside through Approximately 12.6% Stake in Combined Company Significant Near-Term Synergies Expected Given WillScot Mobile Mini’s Track Record of Integrating Acquisitions and Exceeding Identified Synergy Targets Strong Financial Profile, with Combined 2023 Revenues of $3.2 Billion and Adjusted EBITDA of $1.4 Billion1, including Expected $50 Million in Run-Rate Operating Synergies Expecting to Generate Approximately $700 Million of Annual Free Cash Flow2 by End of the First Full Year Following Closing Joint Conference Call Today at 8:00 a.m. ET to Discuss Details of the Transaction PHOENIX and LIVERMORE, Calif., Jan. 29, 2024 (GLOBE NEWSWIRE) — WillScot Mobile Mini Holdings Corp. (“WillScot Mobile Mini” or the “Company”) (Nasdaq: WSC),...

The combination of Novozymes and Chr. Hansen is now successfully completed, creating Novonesis – a leading global biosolutions partner

Written by Customer Service on January 29, 2024. Posted in Public Companies.

Today, the proposed combination of the legacy companies Novozymes and Chr. Hansen is successfully completed, establishing the company Novonesis. Novonesis is a world-leading biosolutions partner for better business, healthier lives, and a healthier planet. The combined company brings together 10,000 people worldwide and an expertise that spans more than 30 different industries. Novonesis is already assisting companies around the world in meeting both business needs and the needs of the planet. COPENHAGEN, Denmark – January 29, 2024. On December 12, 2022, Novozymes and Chr. Hansen entered into an agreement to create a leading global biosolutions partner through a statutory merger of the two companies. All regulatory approvals and registrations are now in place and the proposed combination is successfully completed following the final registration...

Completion of the combination between Novozymes and Chr. Hansen

Written by Customer Service on January 29, 2024. Posted in Public Companies.

January 29, 2024 – Company announcement no. 2Please see attachment.CONTACT INFORMATION Investor Relations Tobias Cornelius Bjorklund +45 3077 8682 tobb@novozymes.com Anders Enevoldsen +45 5350 1453 adev@novozymes.com Press Relations Lina Danstrup +45 3077 0552 lind@novozymes.comAttachmentNo. 2 Completion of the combination between Novozymes and Chr. Hansen

Completion of the combination between Novozymes and Chr. Hansen

Written by Customer Service on January 29, 2024. Posted in Public Companies.

Please read the full announcement in PDFAttachment2024_02_Completion_Of_The_Combination

Form 8.3 – [LXi REIT PLC – 26 01 2024) – (CGWL)

Written by Customer Service on January 29, 2024. Posted in Mergers And Acquisitions.

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION(a) Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree LXi REIT PLC(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e) Date position held/dealing...

Form 8.3 – [YOUNG & CO.’S BREWERY PLC 26 01 2024] – (CGWL)

Written by Customer Service on January 29, 2024. Posted in Mergers And Acquisitions.

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION(a) Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree YOUNG & CO.’S BREWERY PLC(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e) Date...

Day: January 29, 2024

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Cookie Notice